Copyright
©The Author(s) 2020.
World J Gastrointest Pathophysiol. Apr 12, 2020; 11(2): 32-42
Published online Apr 12, 2020. doi: 10.4291/wjgp.v11.i2.32
Published online Apr 12, 2020. doi: 10.4291/wjgp.v11.i2.32
Figure 3 Long term outcome of balsalazide drug shortage on market share through to five years follow-up (compared to persistence on alternative aminosalicylate therapy).
- Citation: van Langenberg DR, Cheng RKY, Garg M. Outcomes of a drug shortage requiring switching in patients with ulcerative colitis. World J Gastrointest Pathophysiol 2020; 11(2): 32-42
- URL: https://www.wjgnet.com/2150-5330/full/v11/i2/32.htm
- DOI: https://dx.doi.org/10.4291/wjgp.v11.i2.32